{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T11:56:43Z","timestamp":1781611003613,"version":"3.54.5"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,9,4]],"date-time":"2025-09-04T00:00:00Z","timestamp":1756944000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,9,4]],"date-time":"2025-09-04T00:00:00Z","timestamp":1756944000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004375","name":"Tel Aviv University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004375","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocrine"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Cushing\u2019s disease (CD) is the most common cause of endogenous Cushing\u2019s syndrome. Adrenocorticotropic hormone (ACTH) has trophic and mitogenic effects on the adrenal cortex that may cause diffuse adrenal enlargement and nodular lesions.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Aim<\/jats:title>\n                    <jats:p>To evaluate the prevalence of adrenal structural abnormalities in patients with CD.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Retrospective cohort study. We conducted a computerized search in our medical centers databases for the diagnosis of CD recorded between the years 1995\u20132024. Out of 124 patients with ACTH dependent Cushing\u2019s syndrome, we identified 68 patients with CD who underwent adrenal imaging. We analyzed the clinical, biochemical, and imaging data.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Our cohort included 68 patients (51 females, 75.0%; mean age at the time of adrenal imaging, 44.6\u2009\u00b1\u200914.9 years). Sixteen (23.5%) patients had an adrenal nodule\n                      <jats:underline>\u2265<\/jats:underline>\n                      10\u2009mm (median size, 27.5\u2009mm, IQR 14.3\u201338.3), and 19 others (27.9%) had adrenal hyperplasia or nodules &lt;10\u2009mm. The prevalence of adrenal nodules increased with age from 16.7% in patients aged 26\u201335 years to 26.3% in those aged above 55. Patients with adrenal nodules were older compared to those with normal adrenal glands (mean age, 49.0\u2009\u00b1\u200912.4 vs 39.1\u2009\u00b1\u200914.9 years;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.03), and had lower ACTH level (0.7 x ULN, IQR 0.5\u20131.2, vs 1.2 x ULN, IQR 0.9\u20131.8,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.02).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>We identified abnormal adrenal imaging in 51.5% of patients with CD. The prevalence of adrenal nodules in our study was 10-fold higher than in the normal population, for all age groups. This suggests that chronic ACTH secretion in CD is associated with adrenal nodules appearance.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s12020-025-04403-8","type":"journal-article","created":{"date-parts":[[2025,9,4]],"date-time":"2025-09-04T18:27:25Z","timestamp":1757010445000},"page":"1501-1508","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["High prevalence of adrenal imaging abnormalities in Cushing\u2019s disease"],"prefix":"10.1007","volume":"90","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-5643-445X","authenticated-orcid":false,"given":"Efrat","family":"Markus","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3220-6321","authenticated-orcid":false,"given":"Yaron","family":"Rudman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0676-8865","authenticated-orcid":false,"given":"Shlomit","family":"Koren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9188-3894","authenticated-orcid":false,"given":"Ilan","family":"Shimon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,4]]},"reference":[{"issue":"12","key":"4403_CR1","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1016\/S2213-8587(21)00235-7","volume":"9","author":"M Fleseriu","year":"2021","unstructured":"M. Fleseriu, R. Auchus, I. Bancos et al. Consensus on diagnosis and management of Cushing\u2019s disease: a guideline update. Lancet Diabetes Endocrinol. 9(12), 847\u2013875 (2021). https:\/\/doi.org\/10.1016\/S2213-8587(21)00235-7","journal-title":"Lancet Diabetes Endocrinol."},{"issue":"2","key":"4403_CR2","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1001\/jama.2023.11305","volume":"330","author":"M Reincke","year":"2023","unstructured":"M. Reincke, M. Fleseriu, Cushing syndrome: a review. JAMA 330(2), 170\u2013181 (2023). https:\/\/doi.org\/10.1001\/jama.2023.11305","journal-title":"JAMA"},{"issue":"10","key":"4403_CR3","doi-asserted-by":"publisher","first-page":"4721","DOI":"10.1210\/en.2004-0491","volume":"145","author":"AP Coll","year":"2004","unstructured":"A.P. Coll, B.G. Challis, G.S.H. Yeo et al. The effects of proopiomelanocortin deficiency on murine adrenal development and responsiveness to adrenocorticotropin. Endocrinology 145(10), 4721\u20134727 (2004). https:\/\/doi.org\/10.1210\/en.2004-0491","journal-title":"Endocrinology"},{"issue":"46","key":"4403_CR4","doi-asserted-by":"publisher","first-page":"18205","DOI":"10.1073\/pnas.0706953104","volume":"104","author":"D Chida","year":"2007","unstructured":"D. Chida, S. Nakagawa, S. Nagai et al. Melanocortin 2 receptor is required for adrenal gland development, steroidogenesis, and neonatal gluconeogenesis. Proc. Natl Acad. Sci. USA 104(46), 18205\u201318210 (2007). https:\/\/doi.org\/10.1073\/pnas.0706953104","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"4403_CR5","doi-asserted-by":"publisher","first-page":"43","DOI":"10.3389\/fendo.2017.00043","volume":"8","author":"X Bertagna","year":"2017","unstructured":"X. Bertagna, Effects of chronic ACTH excess on human adrenal cortex. Front. Endocrinol. 8, 43 (2017). https:\/\/doi.org\/10.3389\/fendo.2017.00043","journal-title":"Front. Endocrinol."},{"issue":"1","key":"4403_CR6","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1507\/endocrj.51.89","volume":"51","author":"T Imaki","year":"2004","unstructured":"T. Imaki, M. Naruse, K. Takano, Adrenocortical hyperplasia associated with ACTH-dependent Cushing\u2019s syndrome: comparison of the size of adrenal glands with clinical and endocrinological data. Endocr. J. 51(1), 89\u201395 (2004). https:\/\/doi.org\/10.1507\/endocrj.51.89","journal-title":"Endocr. J."},{"issue":"4","key":"4403_CR7","doi-asserted-by":"publisher","first-page":"997","DOI":"10.2214\/ajr.172.4.10587135","volume":"172","author":"SA Sohaib","year":"1999","unstructured":"S.A. Sohaib, J.A. Hanson, J.D. Newell-Price et al. CT appearance of the adrenal glands in adrenocorticotrophic hormone-dependent Cushing\u2019s syndrome. AJR Am. J. Roentgenol. 172(4), 997\u20131002 (1999). https:\/\/doi.org\/10.2214\/ajr.172.4.10587135","journal-title":"AJR Am. J. Roentgenol."},{"issue":"1","key":"4403_CR8","doi-asserted-by":"publisher","first-page":"G1","DOI":"10.1093\/ejendo\/lvad066","volume":"189","author":"M Fassnacht","year":"2023","unstructured":"M. Fassnacht, S. Tsagarakis, M. Terzolo et al. European Society of Endocrinology clinical practice guidelines on the management of adrenal incidentalomas, in collaboration with the European Network for the Study of Adrenal Tumors. Eur. J. Endocrinol. 189(1), G1\u2013G42 (2023). https:\/\/doi.org\/10.1093\/ejendo\/lvad066","journal-title":"Eur. J. Endocrinol."},{"issue":"6","key":"4403_CR9","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1210\/endrev\/bnaa008","volume":"41","author":"M Sherlock","year":"2020","unstructured":"M. Sherlock, A. Scarsbrook, A. Abbas et al. Adrenal incidentaloma. Endocr. Rev. 41(6), 775\u2013820 (2020). https:\/\/doi.org\/10.1210\/endrev\/bnaa008","journal-title":"Endocr. Rev."},{"issue":"10","key":"4403_CR10","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.3109\/02841851.2010.516016","volume":"51","author":"L Hammarstedt","year":"2010","unstructured":"L. Hammarstedt, A. Muth, B. W\u00e4ngberg et al. Adrenal lesion frequency: a prospective, cross-sectional CT study in a defined region, including systematic re-evaluation. Acta Radiol. 51(10), 1149\u20131156 (2010). https:\/\/doi.org\/10.3109\/02841851.2010.516016","journal-title":"Acta Radiol."},{"issue":"4","key":"4403_CR11","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1530\/eje.0.1490273","volume":"149","author":"L Barzon","year":"2003","unstructured":"L. Barzon, N. Sonino, F. Fallo, G. Palu, M. Boscaro, Prevalence and natural history of adrenal incidentalomas. Eur. J. Endocrinol. 149(4), 273\u2013285 (2003). https:\/\/doi.org\/10.1530\/eje.0.1490273","journal-title":"Eur. J. Endocrinol."},{"issue":"4","key":"4403_CR12","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1007\/BF03344099","volume":"29","author":"S Bovio","year":"2006","unstructured":"S. Bovio, A. Cataldi, G. Reimondo et al. Prevalence of adrenal incidentaloma in a contemporary computerized tomography series. J. Endocrinol. Invest. 29(4), 298\u2013302 (2006). https:\/\/doi.org\/10.1007\/BF03344099","journal-title":"J. Endocrinol. Invest."},{"issue":"10","key":"4403_CR13","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.7326\/M22-1619","volume":"175","author":"Y Jing","year":"2022","unstructured":"Y. Jing, J. Hu, R. Luo et al. Prevalence and characteristics of adrenal tumors in an unselected screening population: a cross-sectional study. Ann. Intern. Med. 175(10), 1383\u20131391 (2022). https:\/\/doi.org\/10.7326\/M22-1619","journal-title":"Ann. Intern. Med."},{"issue":"5","key":"4403_CR14","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.2214\/AJR.07.2799","volume":"190","author":"JH Song","year":"2008","unstructured":"J.H. Song, F.S. Chaudhry, W.W. Mayo-Smith, The incidental adrenal mass on CT: prevalence of adrenal disease in 1,049 consecutive adrenal masses in patients with no known malignancy. AJR Am. J. Roentgenol. 190(5), 1163\u20131168 (2008). https:\/\/doi.org\/10.2214\/AJR.07.2799","journal-title":"AJR Am. J. Roentgenol."},{"issue":"8","key":"4403_CR15","doi-asserted-by":"publisher","first-page":"e204","DOI":"10.3275\/7349","volume":"34","author":"NM Albiger","year":"2011","unstructured":"N.M. Albiger, G. Occhi, F. Sanguin et al. Adrenal nodules in patients with Cushing\u2019s disease: prevalence, clinical significance and follow-up. J. Endocrinol. Invest. 34(8), e204\u2013e209 (2011). https:\/\/doi.org\/10.3275\/7349","journal-title":"J. Endocrinol. Invest."},{"issue":"5","key":"4403_CR16","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1210\/jcem-50-5-961","volume":"50","author":"DE Schteingart","year":"1980","unstructured":"D.E. Schteingart, H.S. Tsao, Coexistence of pituitary adrenocorticotropin-dependent Cushing\u2019s syndrome with a solitary adrenal adenoma. J. Clin. Endocrinol. Metab. 50(5), 961\u2013966 (1980). https:\/\/doi.org\/10.1210\/jcem-50-5-961","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"2","key":"4403_CR17","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1007\/BF03349849","volume":"19","author":"G Borretta","year":"1996","unstructured":"G. Borretta, M. Terzolo, F. Cesario, I. Meineri, A. Pia, A. Angeli, Coexistence of unilateral adrenal macronodule and Cushing\u2019s disease. Report of two cases. J. Endocrinol. Invest. 19(2), 131\u2013135 (1996). https:\/\/doi.org\/10.1007\/BF03349849","journal-title":"J. Endocrinol. Invest."},{"issue":"1","key":"4403_CR18","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.aace.2020.11.027","volume":"8","author":"MKM Shakir","year":"2022","unstructured":"M.K.M. Shakir, I.C. Ebrahim, A. Spiro, V.Q. Mai, T.D. Hoang, Coexistence of Cushing disease with a solitary adrenocorticotrophic hormone-dependent adrenal adenoma. AACE Clin. Case Rep. 8(1), 41\u201344 (2022). https:\/\/doi.org\/10.1016\/j.aace.2020.11.027","journal-title":"AACE Clin. Case Rep."},{"issue":"1","key":"4403_CR19","doi-asserted-by":"publisher","first-page":"bvab180","DOI":"10.1210\/jendso\/bvab180","volume":"6","author":"FWF Hanna","year":"2022","unstructured":"F.W.F. Hanna, S. Hancock, C. George et al. Adrenal incidentaloma: prevalence and referral patterns from routine practice in a large UK university teaching hospital. J. Endocr. Soc. 6(1), bvab180 (2022). https:\/\/doi.org\/10.1210\/jendso\/bvab180","journal-title":"J. Endocr. Soc."},{"issue":"10","key":"4403_CR20","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1007\/BF03349200","volume":"29","author":"HJLM Timmers","year":"2006","unstructured":"H.J.L.M. Timmers, E.M. van Ginneken, P. Wesseling, C.G.J. Sweep, A.R.M.M. Hermus, A patient with recurrent hypercortisolism after removal of an ACTH-secreting pituitary adenoma due to an adrenal macronodule. J. Endocrinol. Invest. 29(10), 934\u2013939 (2006). https:\/\/doi.org\/10.1007\/BF03349200","journal-title":"J. Endocrinol. Invest."},{"issue":"1","key":"4403_CR21","first-page":"107","volume":"23","author":"J Santos","year":"2010","unstructured":"J. Santos, I. Paiva, L. Gomes et al. [Recurrent hypercortisolism after removal of an ACTH secretor pituitary adenoma associated with an adrenal macronodule]. Acta Med. Port. 23(1), 107\u2013112 (2010)","journal-title":"Acta Med. Port."},{"issue":"2","key":"4403_CR22","first-page":"59","volume":"53","author":"A Tabarin","year":"1992","unstructured":"A. Tabarin, S. Magimel, F. Laurent, A. Navarranne, J. Gu\u00e9rin, P. Roger, [Biological and developmental aspects of macronodular adrenal hyperplasia in Cushing\u2019s disease]. Ann. Endocrinol. 53(2), 59\u201366 (1992)","journal-title":"Ann. Endocrinol."},{"issue":"11","key":"4403_CR23","doi-asserted-by":"publisher","first-page":"5651","DOI":"10.1210\/jc.2018-02209","volume":"104","author":"G Di Dalmazi","year":"2019","unstructured":"G. Di Dalmazi, H.J.L.M. Timmers, G. Arnaldi et al. Somatic PRKACA mutations: association with transition from pituitary-dependent to adrenal-dependent cushing syndrome. J. Clin. Endocrinol. Metab. 104(11), 5651\u20135657 (2019). https:\/\/doi.org\/10.1210\/jc.2018-02209","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"2","key":"4403_CR24","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1210\/en.2018-00775","volume":"160","author":"K Bathon","year":"2019","unstructured":"K. Bathon, I. Weigand, J.T. Vanselow et al. Alterations in protein kinase A substrate specificity as a potential cause of cushing syndrome. Endocrinology 160(2), 447\u2013459 (2019). https:\/\/doi.org\/10.1210\/en.2018-00775","journal-title":"Endocrinology"}],"container-title":["Endocrine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-025-04403-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12020-025-04403-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-025-04403-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T11:43:06Z","timestamp":1781610186000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12020-025-04403-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,4]]},"references-count":24,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4403"],"URL":"https:\/\/doi.org\/10.1007\/s12020-025-04403-8","relation":{},"ISSN":["1559-0100"],"issn-type":[{"value":"1559-0100","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,4]]},"assertion":[{"value":"11 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}